BRIEF published on 11/19/2025 at 23:05, 15 days 9 hours ago Les résultats financiers de Medicure pour le troisième trimestre 2025 reflètent une croissance du chiffre d'affaires malgré une perte nette. Marley Drug Croissance Des Revenus Perte Nette Ventes D'AGGRASTAT® Résultats Financiers De Mediure
BRIEF published on 11/19/2025 at 23:05, 15 days 9 hours ago Medicure's Q3 2025 Financial Results Reflect Revenue Growth Despite Net Loss Revenue Growth Marley Drug Net Loss AGGRASTAT® Sales Medicure Financial Results
PRESS RELEASE published on 11/19/2025 at 23:00, 15 days 9 hours ago Medicure Reports Financial Results for Quarter Ended September 30, 2025 Medicure Inc. reports Q3 2025 results with total net revenue of $8.2 million, an overview of financial performance and key highlights Financial Performance Medicure Inc. Net Revenue Q3 2025 Results Highlights
BRIEF published on 11/13/2025 at 23:35, 21 days 8 hours ago Medicure annoncera ses résultats financiers du troisième trimestre 2025 le 20 novembre Résultats Financiers Medicure Inc. Conférence Téléphonique Produits Pharmaceutiques Américains AGGRASTAT® Et ZYPITAMAG®
BRIEF published on 11/13/2025 at 23:35, 21 days 8 hours ago Medicure to Announce Q3 2025 Financial Results on November 20 Financial Results Conference Call Medicure Inc. U.S. Pharmaceuticals AGGRASTAT® And ZYPITAMAG®
PRESS RELEASE published on 11/13/2025 at 23:30, 21 days 8 hours ago Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025 Medicure Inc. will present Financial Results for Q3 2025 on November 20, 2025, focusing on pharmaceutical development and commercialization in the U.S. market Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 08/20/2025 at 23:35, 3 months 15 days ago Medicure publie ses résultats financiers du deuxième trimestre 2025 Résultats Financiers Perte Nette Revenu Net Investissement Dans La Recherche Entreprise Pharmaceutique
BRIEF published on 08/20/2025 at 23:35, 3 months 15 days ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 3 months 15 days ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 3 months 17 days ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
Published on 12/05/2025 at 02:35, 5 hours 40 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 15 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 10 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 15 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 08:05, 9 minutes ago Smartmi Unveils the Air Purifier 3: Powerful, Smart, and Stylish Air Care for Modern Homes
Published on 12/05/2025 at 08:01, 13 minutes ago Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:01, 13 minutes ago Custodian Property Income REIT plc: Interim results for the period ended 30 September 2025
Published on 12/05/2025 at 08:00, 14 minutes ago Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 08:00, 14 minutes ago Le Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) croît et est sur le point de franchir la barre des 500 millions
Published on 12/04/2025 at 18:14, 14 hours ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 15 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 15 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 30 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 30 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
